Month: May 2019

Intact Vascular Announces $25 Million Financing with Vensana Capital to Drive Commercialization of the Tack Endovascular System®

May 29, 2019 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced a $25 million financing with Vensana Capital as the lead investor.  Vensana was joined by existing investors including New Enterprise Associates (“NEA”), H.I.G. BioHealth Partners, and Quaker Partners.  The Company reported closure of the initial tranche of the financing, with the remainder scheduled for draw down in 2020 as the Company ramps its commercialization of the Tack Endovascular System. 

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

First-of-its-kind study designed to demonstrate safety and efficacy of the Tack Endovascular System® in treating post-PTA dissections  November 6, 2018 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced at the 15th annual VIVA conference in Las Vegas that its Tack Optimized Balloon Angioplasty II (TOBA II) clinical trial …

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial Read More »

Scroll to Top
Intact Vascular uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this.